Cargando…

Cognitive symptoms after COVID-19

INTRODUCTION: SARS-CoV-2 infection frequently causes neurological symptoms. Cognitive alterations are among the most frequent symptoms, and may persist beyond the acute phase of infection. METHODS: We conducted a narrative review of the literature. RESULTS: Hospitalised patients, and especially crit...

Descripción completa

Detalles Bibliográficos
Autores principales: Altuna, M., Sánchez-Saudinós, Mª.B., Lleó, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Neurología. Published by Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669718/
http://dx.doi.org/10.1016/j.neurop.2021.10.005
_version_ 1784614834950635520
author Altuna, M.
Sánchez-Saudinós, Mª.B.
Lleó, A.
author_facet Altuna, M.
Sánchez-Saudinós, Mª.B.
Lleó, A.
author_sort Altuna, M.
collection PubMed
description INTRODUCTION: SARS-CoV-2 infection frequently causes neurological symptoms. Cognitive alterations are among the most frequent symptoms, and may persist beyond the acute phase of infection. METHODS: We conducted a narrative review of the literature. RESULTS: Hospitalised patients, and especially critically ill patients, are at greater risk of developing cognitive symptoms. Post–COVID-19 cognitive symptoms, unlike those associated with other viral illnesses, have been observed in patients with mild infection, and present some atypical features. Cognitive symptoms may last longer in COVID-19 than in other infectious processes, and more frequently affect young people. Post–COVID-19 cognitive symptoms share common features with those described in chronic fatigue syndrome, including a similar profile with affective symptoms. Brief screening tests for cognitive impairment present suboptimal diagnostic performance, and standardised criteria are needed to ensure correct diagnosis. Post–COVID-19 cognitive impairment can have a significant impact on the patient's quality of life and functional independence, regardless of other post–COVID-19 symptoms. Currently, no specific treatments have been approved for post–COVID-19 cognitive impairment, although cognitive stimulation may be useful in some patients. CONCLUSIONS: Post–COVID-19 cognitive symptoms are common and are often associated with other systemic symptoms. Neuropsychological evaluation may be useful for diagnosis and to quantify their severity and long-term prognosis. Detailed, and individualised assessment of cognitive impairment may enable the design of treatment plans.
format Online
Article
Text
id pubmed-8669718
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-86697182021-12-14 Cognitive symptoms after COVID-19 Altuna, M. Sánchez-Saudinós, Mª.B. Lleó, A. Neurology Perspectives Review INTRODUCTION: SARS-CoV-2 infection frequently causes neurological symptoms. Cognitive alterations are among the most frequent symptoms, and may persist beyond the acute phase of infection. METHODS: We conducted a narrative review of the literature. RESULTS: Hospitalised patients, and especially critically ill patients, are at greater risk of developing cognitive symptoms. Post–COVID-19 cognitive symptoms, unlike those associated with other viral illnesses, have been observed in patients with mild infection, and present some atypical features. Cognitive symptoms may last longer in COVID-19 than in other infectious processes, and more frequently affect young people. Post–COVID-19 cognitive symptoms share common features with those described in chronic fatigue syndrome, including a similar profile with affective symptoms. Brief screening tests for cognitive impairment present suboptimal diagnostic performance, and standardised criteria are needed to ensure correct diagnosis. Post–COVID-19 cognitive impairment can have a significant impact on the patient's quality of life and functional independence, regardless of other post–COVID-19 symptoms. Currently, no specific treatments have been approved for post–COVID-19 cognitive impairment, although cognitive stimulation may be useful in some patients. CONCLUSIONS: Post–COVID-19 cognitive symptoms are common and are often associated with other systemic symptoms. Neuropsychological evaluation may be useful for diagnosis and to quantify their severity and long-term prognosis. Detailed, and individualised assessment of cognitive impairment may enable the design of treatment plans. Sociedad Española de Neurología. Published by Elsevier España, S.L.U. 2021-12 2021-12-14 /pmc/articles/PMC8669718/ http://dx.doi.org/10.1016/j.neurop.2021.10.005 Text en © 2021 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Altuna, M.
Sánchez-Saudinós, Mª.B.
Lleó, A.
Cognitive symptoms after COVID-19
title Cognitive symptoms after COVID-19
title_full Cognitive symptoms after COVID-19
title_fullStr Cognitive symptoms after COVID-19
title_full_unstemmed Cognitive symptoms after COVID-19
title_short Cognitive symptoms after COVID-19
title_sort cognitive symptoms after covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669718/
http://dx.doi.org/10.1016/j.neurop.2021.10.005
work_keys_str_mv AT altunam cognitivesymptomsaftercovid19
AT sanchezsaudinosmab cognitivesymptomsaftercovid19
AT lleoa cognitivesymptomsaftercovid19